Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Innovate (VATE) over the last 16 years, with Q3 2025 value amounting to $23.0 million.

  • Innovate's Change in Receivables rose 15555.56% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.4 million, marking a year-over-year increase of 17072.24%. This contributed to the annual value of -$91.8 million for FY2024, which is 45719.84% down from last year.
  • Per Innovate's latest filing, its Change in Receivables stood at $23.0 million for Q3 2025, which was up 15555.56% from $78.9 million recorded in Q2 2025.
  • Innovate's Change in Receivables' 5-year high stood at $78.9 million during Q2 2025, with a 5-year trough of -$93.5 million in Q2 2024.
  • For the 5-year period, Innovate's Change in Receivables averaged around $2.7 million, with its median value being $800000.0 (2021).
  • Per our database at Business Quant, Innovate's Change in Receivables soared by 312500.0% in 2022 and then crashed by 46250.0% in 2024.
  • Over the past 5 years, Innovate's Change in Receivables (Quarter) stood at -$40.0 million in 2021, then tumbled by 78.75% to -$71.5 million in 2022, then soared by 83.64% to -$11.7 million in 2023, then skyrocketed by 114.53% to $1.7 million in 2024, then surged by 1252.94% to $23.0 million in 2025.
  • Its Change in Receivables was $23.0 million in Q3 2025, compared to $78.9 million in Q2 2025 and -$29.2 million in Q1 2025.